Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2013 1
2014 3
2015 3
2016 1
2017 1
2018 4
2019 7
2020 3
2021 7
2022 3
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P, Baber J, Lolkema MP, Steeghs N, de Bruijn E, Shale C, Duyvesteyn K, Haidari S, van Hoeck A, Onstenk W, Roepman P, Voda M, Bloemendal HJ, Tjan-Heijnen VCG, van Herpen CML, Labots M, Witteveen PO, Smit EF, Sleijfer S, Voest EE, Cuppen E. Priestley P, et al. Among authors: labots m. Nature. 2019 Nov;575(7781):210-216. doi: 10.1038/s41586-019-1689-y. Epub 2019 Oct 23. Nature. 2019. PMID: 31645765 Free PMC article.
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.
Beekhof R, Bertotti A, Böttger F, Vurchio V, Cottino F, Zanella ER, Migliardi G, Viviani M, Grassi E, Lupo B, Henneman AA, Knol JC, Pham TV, de Goeij-de Haas R, Piersma SR, Labots M, Verheul HMW, Trusolino L, Jimenez CR. Beekhof R, et al. Among authors: labots m. Sci Transl Med. 2023 Aug 16;15(709):eabm3687. doi: 10.1126/scitranslmed.abm3687. Epub 2023 Aug 16. Sci Transl Med. 2023. PMID: 37585503
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Geurts BS, Battaglia TW, van Berge Henegouwen JM, Zeverijn LJ, de Wit GF, Hoes LR, van der Wijngaart H, van der Noort V, Roepman P, de Leng WWJ, Jansen AML, Opdam FL, de Jonge MJA, Cirkel GA, Labots M, Hoeben A, Kerver ED, Bins AD, Erdkamp FGL, van Rooijen JM, Houtsma D, Hendriks MP, de Groot JB, Verheul HMW, Gelderblom H, Voest EE. Geurts BS, et al. Among authors: labots m. BMC Cancer. 2023 Mar 4;23(1):205. doi: 10.1186/s12885-023-10663-2. BMC Cancer. 2023. PMID: 36870947 Free PMC article.
Genomic landscape of metastatic colorectal cancer.
Haan JC, Labots M, Rausch C, Koopman M, Tol J, Mekenkamp LJ, van de Wiel MA, Israeli D, van Essen HF, van Grieken NC, Voorham QJ, Bosch LJ, Qu X, Kabbarah O, Verheul HM, Nagtegaal ID, Punt CJ, Ylstra B, Meijer GA. Haan JC, et al. Among authors: labots m. Nat Commun. 2014 Nov 14;5:5457. doi: 10.1038/ncomms6457. Nat Commun. 2014. PMID: 25394515 Free PMC article. Clinical Trial.
[Endocrine side effects of checkpoint inhibitors].
Chen WJY, Krul-Poel YHM, Roth C, Labots M, van den Eertwegh AJM, Dreijerink KMA. Chen WJY, et al. Among authors: labots m. Ned Tijdschr Geneeskd. 2019 Oct 31;163:D3957. Ned Tijdschr Geneeskd. 2019. PMID: 31714042 Dutch.
[Rheumatic adverse events due to immune checkpoint inhibitors].
van Binsbergen WH, Heslinga SC, Lems WF, Tsang-A-Sjoe MWP, Labots M, van der Laken J. van Binsbergen WH, et al. Among authors: labots m. Ned Tijdschr Geneeskd. 2023 Nov 1;167:D7698. Ned Tijdschr Geneeskd. 2023. PMID: 37930161 Dutch.
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.
Hoes LR, van Berge Henegouwen JM, van der Wijngaart H, Zeverijn LJ, van der Velden DL, van de Haar J, Roepman P, de Leng WJ, Jansen AML, van Werkhoven E, van der Noort V, Huitema ADR, Gort EH, de Groot JWB, Kerver ED, de Groot DJ, Erdkamp F, Beerepoot LV, Hendriks MP, Smit EF, van der Graaf WTA, van Herpen CML, Labots M, Hoeben A, Morreau H, Lolkema MP, Cuppen E, Gelderblom H, Verheul HMW, Voest EE. Hoes LR, et al. Among authors: labots m. Clin Cancer Res. 2022 Apr 1;28(7):1402-1411. doi: 10.1158/1078-0432.CCR-21-3752. Clin Cancer Res. 2022. PMID: 35046062 Free PMC article.
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors.
van de Geer WS, Mathijssen RHJ, van Riet J, Steeghs N, Labots M, van Herpen C, Devriese LA, Tjan-Heijnen VCG, Voest EE, Sleijfer S, Martens JWM, Cuppen E, van de Werken HJG, Bins S. van de Geer WS, et al. Among authors: labots m. Biomed Pharmacother. 2023 Mar;159:114210. doi: 10.1016/j.biopha.2022.114210. Epub 2023 Jan 6. Biomed Pharmacother. 2023. PMID: 36621142 Free article.
42 results